The present study investigated dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS). A total of forty-five women (aged 25 -40 years) with PCOS and 161 control women (aged 25-43 years) with non-PCOS-related infertility were recruited. Anthropometry, glucose tolerance and sex hormones were determined and dietary intake was assessed. Women with PCOS had lower serum sex hormone-binding globulin and increased BMI, waist:hip ratio, luteinising hormone, ratio of luteinising hormone: follicle-stimulating hormone, testosterone and free androgen index (FAI). Postprandial glucose, fasting insulin and insulin resistance were elevated in women with PCOS. Women with PCOS had reduced energy and carbohydrate intake but higher fat intake. Serum sex hormone-binding globulin level was negatively associated with BMI in both groups and negatively correlated with macronutrient intake in the PCOS group with hyperandrogenism. However, FAI was positively correlated with BMI, waist circumference and glucose metabolic parameters in both groups. Therefore, women with PCOS consume lower energy and carbohydrate compared with those with non-PCOS-related infertility and macronutrient intake is only negatively associated with serum sex hormone-binding globulin level in the PCOS group with hyperandrogenism.
Polycystic ovary syndrome (PCOS), characterised by oligoand/or anovulation, clinical and/or biochemical signs of hyperandrogenism and/or polycystic ovaries (1) , is one of the most common causes of ovulation dysfunction in women of reproductive age. The prevalence of PCOS has been found to range from 2 to 20 % in the general population worldwide (2) , varying depending on the criteria used. According to the National Institutes of Health criteria (1990), Rotterdam consensus criteria (2003) and Androgen Excess Society criteria (2006), the estimated prevalence of PCOS was 8·7, 11·9 -17·8 and 10·2-12·0 %, respectively, in Australia (3) . PCOS can be suspected by clinical and laboratory findings including irregular menstruation or amenorrhea, hirsutism, acne and/or enlarged polycystic ovaries in women with infertility, but excludes other androgen excess or ovulatory disorders, such as congenital adrenal hyperplasia androgen-secreting neoplasms, Cushing's syndrome, thyroid dysfunction, severe insulin resistance, hyperprolactinaemia, or exogenous androgen excess (1, 4) . In addition to abnormal clinical and biochemical signs of hyperandrogenism, insulin resistance, compensatory hyperinsulinaemia and impaired glucose tolerance could increase the risk of type 2 diabetes mellitus and hyperlipidaemia in women with PCOS (5, 6) .
Obesity is common in 30 -70 % women with PCOS (6) . Obesity, in particular of the abdominal type, is present in variable degrees in women with PCOS studied in Europid populations (7, 8) . However, there are a lower prevalence rate of glucose intolerance and lower BMI in Chinese women with PCOS (9) . Obesity plays a crucial role in the pathogenesis of PCOS when accompanied with insulin resistance (10) . About 50 -70 % women with PCOS have insulin resistance and secondary hyperinsulinaemia (11) . Insulin resistance has been † Joint first authors.
reported in non-obese Chinese women with PCOS (12) , indicating that the presence of hyperinsulinaemia in women with PCOS is independent of obesity. Insulin resistance is associated with an increased risk of the metabolic syndrome, diabetes mellitus and CVD (13) . It is hypothesised that controlled body weight and improved insulin resistance may delay or prevent the development of diabetes mellitus and CVD in women with PCOS (6) .
Several studies have revealed that weight loss by diet, exercise and/or behaviour intervention improves body composition, insulin resistance and hyperandrogenism as well as restores menstrual cyclicity and ovulation in overweight or obese women with PCOS (14 -16) . A low-glycaemic index diet has been reported to improve menstrual cyclicity in overweight and obese women with PCOS (16) . However, central obesity and insulin resistance were not strictly correlated with dietary intake including energy and macronutrients in women with PCOS (14) . It is unclear whether dietary intake, glucose metabolism and sex hormones in women with PCOS differ from those with non-PCOS-related infertility and whether the changes in sex hormones are associated with anthropometric measurements, glucose metabolism and/or dietary intake in women with PCOS. Therefore, the present study investigated dietary intake, glucose metabolism and sex hormones in women with PCOS and the correlation between sex hormones and other variables, such as anthropometric measurements, glucose metabolism and dietary intake.
Methods

Subjects
A total of forty-five women with PCOS (aged 25 -40 years) and 161 non-PCOS infertile women of a similar age (25 - (1) . The subjects with non-classic adrenal hyperplasia, 21-hydroxylase deficiency, hyperprolactinaemia, hypothyroidism, androgen-secreting tumours and receiving hormonal therapy were excluded from the present study. The present study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects were approved by the Taiwan Adventist Hospital Institutional Review Board. Written informed consent was obtained from all subjects before the study.
Protocols
The subjects completed the standard form for medical history including menstrual history and anthropometric measurements including height, body weight, BMI, waist circumference and waist:hip ratio (WHR). An overnight fasting blood sample was obtained from the subjects between 08.00 and 10.00 hours during the first 3 d of the menstrual cycle for hormone assays including follicle-stimulating hormone (FSH), luteinising hormone (LH), testosterone and sex hormone-binding globulin (SHBG). Blood samples were stored at 2808C until analysis within 7 d. Blood glucose and insulin levels were measured before and 2 h after a 75 g oral glucose load in 300 ml water. Dietary intake was assessed by 3-d dietary record.
Laboratory assays
Serum FSH, LH, testosterone and SHBG were assessed by commercial RIA kits (Diagnosis System Laboratories, Inc.). Free androgen index (FAI), an indicator of an abnormal androgen status in women, was determined by: FAI ¼ total testosterone ðnmol=lÞ=SHBG ðnmol=lÞ £ 100:
Blood glucose concentration was determined by the glucose oxidase method 30 min after blood was drawn. Serum insulin was analysed by a commercial RIA kit (Diagnosis Products Corp.). Homeostasis model assessment of insulin resistance (HOMA-IR) (17) , an index of insulin resistance, was calculated as:
HOMA 2 IR ¼ fasting glucose ðmmol=lÞ £ fasting insulin ðmU=mlÞ=22·5:
Dietary assessment
The subjects were taught food portion sizes using food photographs and measuring containers and given instructions for the dietary record by a registered dietitian before recording dietary intake. A 3-d dietary record of their usual diets including two weekdays and one weekend was completed by the subjects in the week after blood was drawn. , which is the same cut-off point for ideal weight in the present study. Hyperandrogenism was diagnosed biochemically by a serum testosterone level over 1·7 nmol/l (18) , which was set for the cut-off point. The data among different subgroups in the control and PCOS groups were analysed by one-way ANOVA and Fisher's least significant difference test. The differences between the PCOS and control groups as well as between the two subgroups in women with PCOS were analysed by Student's t test. Correlations between two variables were analysed by simple linear regression and Pearson's correlation coefficient. Multiple linear regression analysis was used for predicting the association of clinical measurements and independent variables, such as characteristics, glucose metabolic parameters and dietary intake. The statistical significance level was set at P,0·05.
Results
Demographic and clinical characteristics
All participants completed anthropometric and clinical measurements and dietary records in the study. The number of women with normal (#1·7 nmol/l), intermediate (1·8-3·1 nmol/l) and high (. 3·1 nmol/l) serum testosterone level in the PCOS group was twenty-four (53 %), eighteen (40 %) and three (7 %), respectively. Of the women, eight controls (5 %) and six with PCOS (13 %) were obese, with BMI $ 27 kg/m 2 defined as obesity in Taiwan, and five controls (3 %) and four with PCOS (9 %) had BMI . 30 kg/m 2 . Body weight (P¼ 0·009), BMI (P¼ 0·033), waist circumference (P¼ 0·005) and WHR (P¼ 0·039) were significantly higher in the PCOS group than those in the control group ( Table 1) .
The PCOS group had significantly increased serum LH (P, 0·0001), LH:FSH (P,0·0001), testosterone (P¼ 0·036) and FAI (P,0·0001), but lowered serum SHBG (P¼ 0·002) compared with the control group ( WHR, waist:hip ratio; FSH, follicle-stimulating hormone; LH, luteinising hormone; SHBG, sex hormone-binding globulin; FAI, free androgen index; HOMA-IR, homeostasis model assessment of insulin resistance. * Mean value was significantly different from that of the BMI , 22 kg/m 2 subgroup in the same group (P, 0·05; one-way ANOVA and Fisher's least significant different test). † Mean value was significantly different from that of the same BMI subgroup of the control group (P,0·05; one-way ANOVA and Fisher's least significant different test). Mean value was significantly different from that of the control group (total): ‡ P,0·05, ‡ ‡ P, 0·0001 (Student's t test). serum insulin (P¼0·009) and HOMA-IR (P¼ 0·007) compared with the corresponding group with BMI , 22 kg/m 2 . Comparing the two subgroups with serum testosterone level # 1·7 or . 1·7 nmol/l, the PCOS group with the mean serum testosterone level of 2·4 nmol/l had significantly higher serum LH level (P¼0·012), LH:FSH (P¼ 0·008) and FAI (P¼0·003) than the group with the mean serum testosterone level of 1·3 nmol/l (Table 2) . However, there were no significant differences in anthropometric measurements, FSH, SHBG, glucose metabolism and dietary intake between two subgroups with serum testosterone level # 1·7 or . 1·7 nmol/l in women with PCOS.
Dietary intake
The PCOS group had significantly lower daily intakes of energy (6311 (SD 1408) v. 6766 (SD 1080) kJ/d; P¼ 0·002) ( Fig. 1(a) ) and carbohydrate (191 (SD 50) v. 222 (SD 45) g/d, P, 0·0001; 51·5 (SD 8·9) v. 55·0 (SD 6·0) % of energy, P, 0·0001) ( Fig. 1(b) and (c)), but a higher fat intake (30·8 (SD 7·9) v. 28·3 (SD 5·1) % of energy; P¼0·0003) ( Fig. 1(c) ) than the control group. However, fat intake in terms of g/d did not differ between the control and PCOS groups (51 (SD 11) v. 53 (SD 17) g/d). Protein intake in the control and PCOS groups (68
Correlations between clinical measurements and anthropometric parameters or dietary intake
Serum FSH level was negatively associated with body weight (r 2 0·19; P¼ 0·016), BMI (r 20·21; P¼0·006), fasting insulin (r 2 0·19; P¼ 0·014), 2-h serum insulin (r 2 0·21; P¼ 0·007) and HOMA-IR (r 20·18; P¼0·022), but positively associated with protein intake (g/d) (r 0·19; P¼0·018) in the control group (Table 3) . Serum LH level was negatively correlated with body weight (r 2 0·16; P¼0·041), BMI (r 20·20; P¼0·013), waist circumference (r 2 0·21; P¼0·009) and WHR (r 2 0·16; P¼0·048) in the control group. Serum testosterone level was significantly negatively associated with age (r 2 0·25; P¼ 0·001), WHR (r 20·18; P¼0·018), energy intake (r 2 0·18; P¼ 0·024) and carbohydrate intake (g/d) (r 20·20; P¼0·013), but positively associated with protein intake (% of energy) (r 0·20; P¼ 0·010) in the control group. Serum SHBG level was negatively correlated with body weight (r 2 0·43, P¼0·0001 v. r 2 0·59, P,0·0001), BMI (r 20·43 v. r 2 0·59; P,0·0001), waist circumference (r 20·42, P, 0·0001 v. r 2 0·55, P¼0·0002), WHR (r 20·22, P¼ 0·031 v. r 20·37, P¼0·006), 2-h serum glucose (r 20·32, P,0·0001 v. r 20·33, P¼ 0·029), 2-h serum insulin (r 20·34, P,0·0001 v. r 2 0·35, P¼0·019) and HOMA-IR (r 2 0·36, P, 0·0001 v. r 20·29, P¼ 0·049) in the control and PCOS groups. However, FAI was positively correlated with body weight (r 0·40 v. 0·55; P, 0·0001), BMI (r 0·38, P,0·0001 v. r 0·52, P¼ 0·0002) and waist circumference (r 0·39, P, 0·0001 v. r 0·46, P¼0·001), 2-h serum glucose (r 0·21, P¼ 0·008 v. r 0·37, P¼0·013), fasting insulin (r 0·38, P,0·0001 v. r 0·41, P, 0·05), 2-h serum insulin (r 0·30, P¼ 0·0001 v. 0·54, P¼ 0·0001) and HOMA-IR (r 0·39, P,0·0001 v. r 0·38, P¼0·009) in the control and PCOS groups. FAI was negatively associated with fat intake (g/d) (r 2 0·15; P¼0·048) in women with PCOS.
Fasting glucose level was positively correlated with body weight (r 0·19; P¼0·018) and BMI (r 0·15; P¼ 0·043) in the control group (Table 4 ). The levels of 2-h serum glucose, fasting insulin, 2-h serum insulin and HOMA-IR were positively associated with body weight (r 0·18-0·30, P¼ 0·001-0·020 v. r 0·37-0·61, P, 0·0001-0·012), BMI (r 0·19-0·33, P,0·0001-0·01 v. r 0·45-0·64, P, 0·0001 -0·002) and waist circumference (r 0·27-0·34, P, 0·0001 -0·0006 v. r 0·37-0·55, P,0·0001-0·012) in the control and PCOS groups. Fasting insulin level and HOMA-IR were positively correlated with WHR (r 0·18, P¼0·031-0·038 v. r 0·40-0·41, P¼0·005-0·006) in the control and PCOS groups.
Protein intake in terms of g/d and percentage of energy was negatively associated with fasting insulin (r 20·19, 
FSH, follicle-stimulating hormone; LH, luteinising hormone; SHBG, sex hormone-binding globulin; FAI, free androgen index; WHR, waist:hip ratio; HOMA-IR, homeostasis model assessment of insulin resistance. * P,0·05, ** P,0·01, *** P,0·001. Table 4 . Relationships between blood glucose, insulin, or insulin resistance and characteristics or dietary intake in the control (n 161) and polycystic ovary syndrome (PCOS; n 45) groups (Pearson's correlation coefficients (r))
0·19* 0·12 0·18* 0·37* 0·29*** 0·61*** 0·20* 0·54*** 0·30*** 0·60*** BMI (kg/m 2 ) 0·15* 0·15 0·19* 0·45** 0·33*** 0·64*** 0·28*** 0·60*** 0·33*** 0·63*** Waist (cm) 0·16 0·12 0·27*** 0·37* 0·33*** 0·55*** 0·29*** 0·45* 0·34*** 0·53*** WHR 0·05 0·17 0·26** 0·30 0·18* 0·41** 0·22* 0·26 0·18* 0·40**
HOMA-IR, homeostasis model assessment of insulin resistance; WHR, waist:hip ratio. * P,0·05, ** P,0·01, *** P,0·001.
P¼ 0·018 v. r 2 0·16, P¼0·039) and HOMA-IR (r 2 0·18, P¼ 0·025 v. r 2 0·15, P¼0·052) in the control group (Table 4) . However, energy and macronutrient intakes were not significantly correlated with glucose metabolic parameters in women with PCOS.
The multiple linear regression analysis showed that serum LH level tended to be negatively associated with WHR (b 2 14·325; P¼ 0·052) in the control group (Table 5) . Serum testosterone level was negatively correlated with age (b20·029; P¼0·010) and energy intake (b 2 0·0001; P¼ 0·017) in the control group. Serum SHBG level was negatively associated with BMI (b 22·764; P¼0·001) and fasting insulin level (b 20·279; P¼0·022) in the control group. Serum testosterone level was negatively associated with age (b 2 0·279; P¼ 0·008) and 2-h insulin level (b 2 0·279; P¼ 0·025) in the PCOS group. Serum SHBG level was only negatively associated with BMI (b 2 3·394; P¼0·007) in the PCOS group, and a correlation (b 2 6·325; P¼0·009) also existed in the PCOS group with serum testosterone level # 1·7 nmol/l (Table 6 ). Serum SHBG level was negatively correlated with macronutrient intake (carbohydrate: b 24404·103, P¼ 0·043; protein: b 2 4520·923, P¼0·047; fat: b 24376·076, P¼0·044) in the PCOS group with serum testosterone level . 1·7 nmol/l. Consistent with the findings using a simple linear regression model, the results indicated that BMI was a better predictive indicator for serum SHBG level in both the control and Table 5 . Relationships between sex hormones and independent variables including characteristics, glucose metabolic parameters and dietary intake in the control and polycystic ovary syndrome (PCOS) groups using a multiple linear regression model
FSH, follicle-stimulating hormone; LH, luteinising hormone; SHBG, sex hormone-binding globulin; WHR, waist:hip ratio. * P,0·05, ** P,0·01, *** P,0·001. Table 6 . Relationships between sex hormones and independent variables including characteristics, metabolic parameters and dietary intake in the polycystic ovary syndrome group (n 45) by serum testosterone level using a multiple linear regression model
FSH, follicle-stimulating hormone; LH, luteinising hormone; SHBG, sex hormone-binding globulin; WHR, waist:hip ratio. P,0·05, ** P, 0·01. PCOS groups. Serum FSH level was negatively associated with WHR (b 2 29·323; P¼ 0·043) in the PCOS group with serum testosterone level . 1·7 nmol/l. However, serum LH level was not significantly associated with characteristics (age, BMI and WHR), glucose metabolic parameters (blood glucose and insulin levels) and dietary intake (energy and macronutrients) in the PCOS group with or without hyperandrogenism.
Discussion
Similar to the findings of previous studies (5, 19, 20) , women with PCOS had higher BMI than control women. Some of the studies have demonstrated that obesity commonly exists in 30 -70 % women with PCOS (4,6,20 -22) . However, our data showed that only 13 % women with PCOS had BMI $ 27 kg/m 2 and most women with PCOS were non-obese (BMI 23·0 (SD 4·4) kg/m 2 ), which is consistent with the study of women with PCOS (BMI 22·7 (SD 4·1) kg/m 2 ) in southern China (23) . Therefore, the prevalence of obesity in women with PCOS is different between Chinese and Caucasian women. Overweight and obesity in women with PCOS exacerbated the severity of hyperandrogenism and impaired the metabolic profiles (24) . The present study showed that women with PCOS also had higher waist circumference and WHR than control women, indicating that women with PCOS could have more abdominal fat. In addition, FAI was positively correlated with BMI, waist circumference and HOMA-IR in women with PCOS. Regardless of overweight or obesity, the development of PCOS was strongly associated with weight gain and abdominal fat was correlated with hyperandrogenism and insulin resistance in women with PCOS (25, 26) .
The clinical measurements varied due to different ethnic groups, BMI and hormone levels. The PCOS group with the mean age of 32·7 years and the mean BMI of 23·0 kg/m 2 in the present study had higher mean serum FSH (6·8 v. 5·0 IU/l), LH (7·3 v. 6·2 IU/l), testosterone (1·8 v. 1·4 nmol/l) and SHBG (49·4 v. 20·4 nmol/l) levels, but lower FAI (4·68 v. 7·38) and HOMA-IR (1·8 v. 3·3) compared with PCOS patients with a mean age of 27·7 years and a mean BMI of 34·1 kg/m 2 in Bahrain (27) . The PCOS group in the present study had a higher mean FSH level (6·8 v. 5·0 IU/l), but lower LH level (7·3 v. 13·0 IU/l), LH:FSH (1·1 v. 2·6), testosterone (1·8 v. 3·2 nmol/l) and FAI (4·68 v. 11·3) compared with PCOS patients with a mean age of 32·2 years and a mean BMI of 29·9 kg/m 2 in the UK (28) . The PCOS group in the present study had lower BMI and FAI compared with the previous studies (27, 28) , which is consistent with our findings that FAI was reduced with decreased BMI in women with PCOS.
The present study demonstrated that women with PCOS had higher serum LH, LH:FSH, serum testosterone and FAI and lower serum SHBG levels, which is consistent with hormonal changes for the diagnosis of PCOS. A previous study found that obese women with PCOS had significantly higher serum total testosterone levels than non-obese women with PCOS (29) . However, the present study showed that in the PCOS group serum testosterone level was not significantly different in the group with BMI $ 22 kg/m 2 compared with the group with BMI ,22 kg/m 2 , which is consistent with our findings that serum testosterone level was associated with neither BMI nor waist circumference in women with PCOS. The different findings could be attributed to different proportions of overweight and obese women with PCOS and degree of hyperandrogenism.
The changes in hormones including serum SHBG and FAI were greater in women with PCOS with BMI $ 22 kg/m 2 compared with those with BMI ,22 kg/m 2 , suggesting that hormonal changes are strongly associated with BMI. In agreement with a previous study (30) , serum SHBG level was negatively associated with body weight, BMI and waist circumference, while FAI was positively associated with these parameters mentioned above, in women with PCOS. In addition, as compared with women with PCOS who had BMI ,22 kg/m 2 , those with BMI $22 kg/m 2 had significantly increased 2-h serum glucose, fasting insulin, 2-h serum insulin and HOMA-IR which were positively correlated with body weight, BMI and waist circumference. Women with PCOS and impaired glucose metabolism had higher incidences of glucose intolerance and type 2 diabetes mellitus (5, 31) . Therefore, it is reasonable to suspect that increased BMI in women with PCOS impairs insulin sensitivity which can further influence hyperandrogenism. Insulin insensitivity was found to possibly contribute to hyperandrogenism (32) . Elevated insulin level and HOMA-IR in women with PCOS who had higher BMI values in the present study could contribute to the increases in serum testosterone and FAI. Increased insulin level also possibly leads to lower serum SHBG. There was a strong negative correlation between fasting insulin level and serum SHBG in obese hyperandrogenic women (33) and women with PCOS (34) . Martens et al. (35) hypothesised that serine hyperphosphorylation of cytochrome P450c17 increasing 17,20-lyase activity and androgen production may cause hyperandrogenism and serine hyperphosphorylation of insulin receptor-b inhibiting its tyrosine phosphorylation may cause insulin resistance in women with PCOS. A previous study in the UK reported that women with PCOS who had a mean BMI of 27·4 kg/m 2 consumed 38 % of energy intake from fat (36) , which was higher than that (31 %) in those with the mean BMI of 23·0 kg/m 2 in the present study. Similar to the present results for macronutrient intake (18, 31 and 51 % of energy intake from protein, fat and carbohydrate, respectively) in women with PCOS, a previous study in Italy showed that habitual intake for protein, fat and carbohydrate was 16, 33 and 52 % of energy intake, which was a similar distribution between women with PCOS and hypothalamic amenorrhea (37) . The consumption of energy and macronutrients was not significantly different between women with PCOS and age-, race-and BMI-matched healthy women in the study by Douglas et al. (38) . However, women with PCOS consumed more high-glycaemic index foods, such as white bread (7·9 (SD 4·4) v. 5·5 (SD 2·9) servings over 4 d; P, 0·05) and fried potatoes (1·0 (SD 1·5) v. 0·4 (SD 0·7) servings over 4 d; P¼0·07) than did the healthy control group (38) . The present study found that women with PCOS had lower energy and carbohydrate intake but higher fat intake than infertile women without PCOS. The different findings between the study by Douglas et al. (38) (40) . The average intake (g/d) for carbohydrate, fat and protein was 102, 88 and 96 % in the control group (222, 51 and 68 g/d) compared with those (218, 58 and 71 g/d) in healthy women aged 31 to 64 years in Taiwan (39) , while the PCOS group had 88, 91 and 94 % of the average intake for carbohydrate, fat and protein (191, 53 and 67 g/d). However, energy intake from carbohydrate, fat and protein in women with PCOS (51·5, 30·8 and 17·6 %) was close to those (51·8, 31·2 and 17·0 %) in healthy women aged 31 -64 years in Taiwan.
Weight loss through energy restriction has been demonstrated to positively affect metabolic and hormonal profiles in women with PCOS (24) . The present study revealed that women with PCOS had lower intakes of energy, carbohydrate and percentage of energy from carbohydrate but a higher percentage of energy from fat. However, women with PCOS had higher BMI and waist circumference. This is probably due to decreased energy intake for weight loss in non-obese women with PCOS and higher BMI. However, the measurement error of using dietary records for dietary assessment cannot be ruled out, although the 3-d dietary record reflects current dietary intake more accurately and specifically than dietary recall and FFQ. Dietary composition and energy distribution from macronutrients could also contribute to higher BMI in women with PCOS. However, in agreement with the present study, daily intake of energy and macronutrients has not been found to be associated with insulin resistance (38, 41) . Other nutrients or food components, such as dietary fibre and antioxidants, could cause metabolic and hormonal changes in women with PCOS. Protein intake was negatively correlated with fasting insulin level and HOMA-IR in the control group but not in women with PCOS, indicating that there could be various relationships between dietary intake and glucose metabolic parameters in the control and PCOS groups due to different anthropometric, metabolic and nutritional status.
Due to the different proportions of overweight and obese women with PCOS and degree of hyperandrogenism between the present study and others carried out in Europid populations, generalisation of the present results is considered to be limited for those non-obese women with PCOS. In conclusion, women with PCOS have lower serum SHBG levels negatively correlated with HOMA-IR and higher FAI positively correlated with HOMA-IR compared with those with non-PCOS-related infertility. Women with PCOS have lower energy and carbohydrate intakes but higher fat intakes, and macronutrient intake is only negatively associated with serum SHBG level in the PCOS group with hyperandrogenism. To minimise the influence of BMI and hyperandrogenism, the comparisons between non-obese and obese women with PCOS and between those with and without hyperandrogenism should be studied further to investigate whether dietary intake or habit is associated with the morbidity of PCOS. In addition, only 3-d dietary records were used for dietary intake evaluation in the present study; 7-d weighed food diaries could be considered for the assessment of dietary habit and under-reporting in women with PCOS in a future study.
